Skip to content

Assessment of risk factors for type 2 diabetic foot ulcers and health economics analysis

Assessment of risk factors for type 2 diabetic foot ulcers and health economics analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094915
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetic foot ulcer

Interventions

Observation group:None

Sponsors

The Affiliated Hospital of Yunnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for type 2 diabetes mellitus in 1999; 2. Age 18-79 years old; 3. Complete clinical data records (accounting for more than 2/3 of the items required for the study); 4. Length of hospital stay>=1 d. Note: In 1999, the World Health Organization proposed the diagnostic criteria for diabetes mellitus: typical symptoms of diabetes mellitus (polydipsia, polydipsia, polyuria, increased diet, and unexplained weight loss) and random blood glucose test > = 11.1 mmol/L or fasting blood glucose level > = 7.0 mmol/L or glucose index 2 hours after glucose load > = 11.1 mmol/L (diagnosed according to the above criteria or previous medical records).

Exclusion criteria

Exclusion criteria: 1. Severe liver and kidney diseases, fever, infection, angina, myocardial infarction, transient ischemic attack, stroke, acromegaly, thyroid disease and other endocrine diseases; 2. Central or peripheral neuropathy caused by mental and psychological diseases and other reasons, cerebrovascular diseases, lumbar spine diseases, toxic peripheral neuritis, infectious polyneuritis, chronic alcoholism, systemic lupus erythematosus, uremia, lateral sclerosis; 3. Non-diabetic podiatry, limb ulcers, deformities, trauma, infection and edema, malignant tumors; 4. Pregnancy; 5. There is a lack of data on the first page of the medical record; 6. The diagnostic information is not standardized.

Design outcomes

Primary

MeasureTime frame
Blood uric acid (SUA)/high-density lipoprotein cholesterol (HDL-C) ratio;Triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) ratio;HALP score (hemoglobin (g/L)× albumin (g/L)× lymphocytes (/L)/platelets (/L));Erythrocyte distribution width, RDW/albumin (ALB) ratio;Ratio of erythrocyte distribution width to RDW/AIB;Erythrocyte distribution width vs. RDW/platelet distribution width (PDW);Hemoglobin (Hb)/platelet distribution width (RDW);Platelet-to-lymphocyte ratio (PLR);Neutrophil-to-lymphocyte ratio (NLR);Lymphocyte-to-monocyte ratio (LMR);The cost of this hospitalization;Percentage of antibiotic cost;

Secondary

MeasureTime frame
Vibrosensory Threshold (VPT);Glycosylated hemoglobin;Ankle-brachial index;Erythrocyte sedimentation rate;Kidney function;Liver function part of the item;Coagulation function;Electrolyte Project;Blood lipids;Routine blood items;

Countries

China

Contacts

Public ContactWang Zhi

The Affiliated Hospital of Yunnan University

2369959730@qq.com+86 184 8721 1913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026